Symptomatic severe aortic stenosis is associated with high mortality rates, up to 50% at 1 year,1 and the prevalence will likely increase as the population ages.2 Until recently, surgical valve replacement was the only durable therapeutic option; however, many older patients with aortic stenosis have prohibitive surgical risk. Transcatheter aortic valve replacement (TAVR) has emerged as an option for these patients and, more recently, for patients with high and moderate surgical risk. We identified trends in mortality due to aortic stenosis, considering these recent therapeutic advances.
Bevan GH, Zidar DA, Josephson RA, Al-Kindi SG. Mortality Due to Aortic Stenosis in the United States, 2008-2017. JAMA. 2019;321(22):2236–2238. doi:10.1001/jama.2019.6292
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: